Matomo


CADASIL, Moyamoya (NEUROVASC-WG)

Research Publications

Our publications cover a wide range of topics, including the latest research on diagnostic tools, innovative therapies, and management strategies for rare vascular diseases. This page provides a list of publications from the Neurovascular Diseases Working Group (NEUROVASC-WG) to help researchers and healthcare professionals stay up-to-date on the latest developments in the field.

Results (3)
























The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies – A Consensus Review from the NEUROVASC Working Group
October 02 2025

Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A. The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group. Eur J Neurol. 2025 Oct;32(10):e70316. doi: 10.1111/ene.70316. PMID: 41039799; PMCID: PMC12491649.

*VASCERN acknowledged


Progression of initially unilateral Moyamoya angiopathy in Caucasian Europeans
June 01 2023

Strunk D, Diehl RR, Veltkamp R, Meuth SG, Kraemer M. Progression of initially unilateral Moyamoya angiopathy in Caucasian Europeans. J Neurol. 2023 Sep;270(9):4415-4422. doi: 10.1007/s00415-023-11793-0. Epub 2023 Jun 1. PMID: 37261501.


European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)
February 02 2023

Bersano A, Khan N, Fuentes B, Acerbi F, Canavero I, Tournier-Lasserve E, Vajcoczy P, Zedde ML, Hussain S, Lémeret S, Kraemer M, Herve D. European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN). Eur Stroke J. 2023 Mar;8(1):55-84. doi: 10.1177/23969873221144089. Epub 2023 Feb 2. PMID: 37021176; PMCID: PMC10069176.


Skip to content